Gillian M Cochrane, Magdelene Mangot, Wendy Houinei, Melinda Susapu, Anasaini Cama, Richard Le Mesurier, Sara Webster, Tessa Hillgrove, Jaki Barton, Robert Butcher, Emma M Harding-Esch, David Mabey, Ana Bakhtiari, Andreas Müller, Aya Yajima, Anthony W Solomon, John Kaldor, Samuel Peter Koim, Robert Ko, Jambi Garap
PURPOSE: The prevalence of trachomatous inflammation-follicular (TF) in Papua New Guinea (PNG) suggests antibiotic mass drug administration (MDA) is needed to eliminate trachoma as a public health problem but the burden of trichiasis is low. As a result, WHO issued bespoke recommendations for the region. If ≥ 20% of 10-14-year-olds have both any conjunctival scarring (C1 or C2 or C3) and corneal pannus and/or Herbert's pits, MDA should be continued. Equally, if ≥ 5% of that group have both moderate/severe conjunctival scarring (C2 or C3) and corneal pannus and/or Herbert's pits, MDA should be continued...
February 8, 2024: Ophthalmic Epidemiology